Ygal Rotenstreich
Tel Aviv, TA, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Thrombin is increased in diabetic retinal pathology in the STZ mice model, and its attenuation by a specific inhibitor, PARIN5, is associated with preserved function.
Journal: Scientific reports
Published: January 28, 2026
Towards noninvasive blood count using a deep learning pipeline from bulbar conjunctiva videos.
Journal: NPJ digital medicine
Published: July 18, 2025
Housing RCS rats under specific pathogen-free conditions mildly ameliorates retinal degeneration and alters intestine microbiota.
Journal: Scientific reports
Published: April 07, 2024
Efficacy and safety of injecting increasing volumes into the extravascular spaces of the choroid using a blunt adjustable depth injector.
Journal: International ophthalmology
Published: April 27, 2020
Chromatic pupilloperimetry for objective diagnosis of Best vitelliform macular dystrophy.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: March 19, 2019
In vivo MRI assessment of bioactive magnetic iron oxide/human serum albumin nanoparticle delivery into the posterior segment of the eye in a rat model of retinal degeneration.
Journal: Journal of nanobiotechnology
Published: November 13, 2018
Synthetic 9-cis-beta-carotene inhibits photoreceptor degeneration in cultures of eye cups from rpe65rd12 mouse model of retinoid cycle defect.
Journal: Scientific reports
Published: November 02, 2017
Bioactive magnetic near Infra-Red fluorescent core-shell iron oxide/human serum albumin nanoparticles for controlled release of growth factors for augmentation of human mesenchymal stem cell growth and differentiation.
Journal: Journal of nanobiotechnology
Published: September 28, 2014
Treatment of a retinal dystrophy, fundus albipunctatus, with oral 9-cis-{beta}-carotene.
Journal: The British journal of ophthalmology
Published: December 04, 2009
Showing 1-11 of 11
Last Updated: 09/26/2026